Step 1 topics → Musculoskeletal, Skin, and Connective Tissue → Dermatitis Herpetiformis

Dermatitis Herpetiformis

USMLE Step 1 trap: Confuses the granular IgA deposits of dermatitis herpetiformis with the linear IgG deposits of bullous pemphigoid. Dermatitis herpetiformis involves granular IgA deposition at the dermal papillae tips, distinguishing it from the linear IgG/C3 of bullous pemphigoid.

Dermatitis herpetiformis (DH) is the skin manifestation of celiac disease — not a separate disease, not a coincidence — and USMLE Step 1 tests it precisely because students treat it as a pure skin condition and miss the systemic connection. IgA antibodies against tissue transglutaminase (from gluten sensitivity) cross-react with epidermal transglutaminase and deposit in granular clumps at the tips of dermal papillae. This triggers neutrophil recruitment, microabscess formation, and intensely pruritic vesicles on extensor surfaces. The two reliable exam traps: confusing the granular IgA pattern with the linear IgG/C3 of bullous pemphigoid, and forgetting to check G6PD status before prescribing dapsone.

The exam tests DH from three angles: recognizing the clinical presentation (grouped, pruritic vesicles on elbows, knees, buttocks), understanding the immunopathology (granular IgA at dermal papillae — not linear, not IgG), and knowing the management hierarchy (gluten-free diet is definitive; dapsone is fast but carries real risks). Passage-based questions often give you a patient with GI symptoms plus a skin finding and ask you to connect them, or show you a biopsy description and ask you to distinguish DH from bullous pemphigoid.

The two biggest traps: confusing the granular IgA pattern with the linear IgG/C3 of bullous pemphigoid, and treating DH as unrelated to celiac disease. A third trap shows up in management questions — dapsone is the go-to for quick symptom control, but USMLE Step 1 will absolutely ask about hemolytic anemia in G6PD-deficient patients or methemoglobinemia before you can prescribe it safely.

From real student decks
3%have cards covering this topic
0%have mature cards

A gap in most decks — fewer than half of students in our cohort have cards covering this topic.

Common misconceptions

Common mistake
Wrong: Dermatitis herpetiformis involves IgG deposition at the dermal-epidermal junction like bullous pemphigoid.
Right: Dermatitis herpetiformis involves granular IgA deposition at the dermal papillae tips, distinguishing it from the linear IgG/C3 of bullous pemphigoid.
Bullous pemphigoid involves IgG and C3 deposited in a linear band at the dermal-epidermal junction targeting hemidesmosomes. DH is fundamentally different: the deposits are IgA, they are granular (not linear), and they sit at the tips of dermal papillae. On a biopsy question, the words 'granular IgA' should immediately trigger DH, while 'linear IgG/C3' means bullous pemphigoid — these two patterns are non-interchangeable on the exam.
Common mistake
Wrong: Dermatitis herpetiformis is an independent skin disease unrelated to gastrointestinal pathology.
Right: Dermatitis herpetiformis is the cutaneous manifestation of celiac disease; anti-tissue transglutaminase IgA antibodies cross-react with epidermal transglutaminase, and a gluten-free diet improves both conditions.
DH is not a standalone skin disease — it is celiac disease manifesting in the skin. The mechanism is specific: IgA antibodies originally directed at tissue transglutaminase (the autoantigen in celiac disease) cross-react with epidermal transglutaminase, driving the skin lesions. This is why a strict gluten-free diet improves or resolves both the intestinal symptoms and the rash; if a question asks about DH management, 'gluten-free diet' is always part of the correct answer.
Common mistake
Gap: Misses the need to screen for G6PD deficiency before starting dapsone in dermatitis herpetiformis
Dapsone, used to rapidly control pruritus in dermatitis herpetiformis, causes hemolytic anemia in G6PD-deficient patients and methemoglobinemia; G6PD screening before initiation is essential.
Dapsone is an oxidant drug — it works quickly to relieve the miserable pruritus of DH, but it generates reactive oxygen species that destroy RBCs lacking G6PD-mediated antioxidant protection. In G6PD-deficient patients, this causes acute hemolytic anemia; in anyone, high doses can cause methemoglobinemia (functional anemia with a classic 'chocolate brown' blood description). Screen for G6PD deficiency before starting dapsone — this is a classic Step 1 'before you prescribe' question.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Recognize the classic presentation: intensely pruritic, grouped vesicles on extensor surfaces (elbows, knees, buttocks) that prompt biopsy showing neutrophilic microabscesses at dermal papillae tips.
  2. Identify the immunofluorescence pattern that defines DH: granular IgA deposits at dermal papillae tips — and distinguish this from the linear IgG/C3 pattern seen in bullous pemphigoid.
  3. Understand the obligate link between DH and celiac disease: anti-tTG IgA antibodies cross-react with epidermal transglutaminase, meaning a gluten-free diet treats both the gut and the skin.
  4. Apply the management strategy correctly: gluten-free diet is the definitive treatment, dapsone provides rapid pruritus relief, but G6PD status must be checked before starting dapsone due to risk of hemolytic anemia and methemoglobinemia.

Can you avoid these mistakes?

A 28-year-old woman presents with intensely pruritic grouped vesicles on her elbows and buttocks. She also reports intermittent bloating and diarrhea. Skin biopsy shows neutrophilic microabscesses at the tips of dermal papillae with granular IgA on immunofluorescence. What is the diagnosis, and what single dietary intervention addresses both her skin and GI symptoms?
You are shown two biopsy immunofluorescence reports: (A) linear IgG and C3 at the dermal-epidermal junction; (B) granular IgA at dermal papillae tips. Which pattern corresponds to dermatitis herpetiformis, which to bullous pemphigoid, and what autoantigen is targeted in each?
A patient with newly diagnosed dermatitis herpetiformis wants immediate relief from itching while starting a gluten-free diet. You plan to prescribe dapsone. What must you check before writing the prescription, and what two serious adverse effects are you trying to prevent?
A patient with dermatitis herpetiformis asks whether their skin disease is 'just a skin thing.' How do you explain the pathophysiologic connection between their gluten sensitivity and the skin lesions at a mechanistic level?

Related topics

Bone Cells and Matrix Endochondral vs Membranous Ossification Fracture Healing Stages Compartment Syndrome

See how your Anki deck covers this topic.

Upload your deck for a free audit →